neobookRx
Articles

Singapore sets global first by reaching WHO’s highest classification for medical device regulation

The WHO announced today that Singapore’s Health Sciences Authority (HSA) has achieved the highest level of regulatory performance for medical devices under WHO’s global benchmarking framework.

The designation confirms that Singapore’s regulatory system operates at an advanced level of performance with mechanisms for continuous improvement, and consistently ensures the safety, quality and performance of medical devices throughout their life cycle, from market authorisation and clinical evaluation to post-market surveillance. 

Click here to access the article.

NeoHealth® ID 39182 · updated 4/10/2026